Personensuche

Personensuche

Bitte geben Sie den Namen der gesuchten Person ein.

Es wurde 1 Person gefunden.

Dr. med. Harald Lahner

E-Mail
harald.lahner@uk-essen.de

Funktionen

  • Wiss. Mitarbeiter/in und Wiss. Assistent/in, Klinik für Endokrinologie

Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.

    Artikel in Zeitschriften

  • Machlah, Yara Maria; Brandenburg, Tim; Muchalla, Philipp; Tiedje, Vera; Theurer, Sarah; Weber, Manuel; Weber, Frank; Dralle, Henning; Lahner, Harald; Führer, Dagmar
    Comprehensive Assessment of Multikinase Inhibitor Therapy Outcomes in RAIR-(P)DTC and MTC at a Tertiary Referral Center
    In: The Journal of Clinical Endocrinology & Metabolism (JCEM), 2025, in press
    DOI
  • Mathew, Annie; Hauptmeier, Pia; Schaarschmidt, Benedikt; Fendler, Wolfgang; Führer, Dagmar; Lahner, Harald
    High incidence and poor prognosis of bone metastases in functioning small intestinal neuroendocrine tumors
    In: Frontiers in Endocrinology, Jg. 16, 2025, 1680209
    DOI (Open Access)
  • Lahner, Harald; Mathew, Annie; Brägelmann, Johanna; Fendler, Wolfgang; Weber, Frank; Theurer, Sarah; Rahe, Gilbert; Führer, Dagmar
    Hormonsyndrome bei neuroendokrinen Tumoren : Richtig diagnostizieren und behandeln
    In: Die Gastroenterologie, Jg. 20, 2025, Nr. 6, S. 434 – 444
    DOI
  • Mathew, Annie; Kersting, David; Fendler, Wolfgang; Braegelmann, Johanna; Führer, Dagmar; Lahner, Harald
    Impact of functionality and grading on survival in pancreatic neuroendocrine tumor patients receiving peptide receptor radionuclide therapy
    In: Frontiers in Endocrinology, Jg. 16, 2025, 1526470
    DOI, Online Volltext (Open Access)
  • Mathew, Annie; Capdevila, Jaume; Unger, Nicole; Fendler, Wolfgang; Theurer, Sarah; Weber, Frank; Führer, Dagmar; Lahner, Harald
    Lenvatinib as salvage therapy in advanced and progressive GI-NET
    In: Endocrine-Related Cancer, Jg. 32, 2025, Nr. 8, e250165
    DOI
  • Veldhuis, W B; Walter, T; de Vries-Huizing, D M V; Theysohn, J; Barton, S; Ekkelenkamp, E D; Lachachi, B; de Jong, R J G; van Golen, L W; Lanzafame, H; Milot, L; Lahner, Harald; Lam, M E G H; Tesselaar, M E T; Braat, A J A T
    PRRT plus holmium-166-SIRT (HEPAR PLuS) versus PRRT-only in patients with metastatic neuroendocrine tumors : A propensity-score matched analysis
    In: Journal of Neuroendocrinology, Jg. 37, 2025, Nr. 8, e70034
    DOI (Open Access)
  • Braegelmann, Johanna; Mathew, Annie; Schmidt, Börge; Kalisch, Hamza; Fendler, Wolfgang; Führer-Sakel, Dagmar; Lahner, Harald
    Somatostatin analogs in neuroendocrine tumors with Ki-67 index of ≥10%
    In: Journal of Neuroendocrinology, 2025, in press
    DOI (Open Access)
  • Ciuciulkaite, Ieva; Herrmann, Ken; Lahner, Harald
    Stellenwert der Peptid-Radio-Rezeptor-Therapie für das Management neuroendokriner Tumoren
    In: Die Radiologie, Jg. 65, 2025, Nr. 5, S. 371 – 380
    DOI
  • Weber, Manuel; Pettersson, Olof; Seifert, Robert; Schaarschmidt, Benedikt; Fendler, Wolfgang; Rischpler, Christoph; Lahner, Harald; Herrmann, Ken; Sundin, Anders
    Changes in tumor-to-blood ratio as a prognostic marker for progression-free survival and overall survival in neuroendocrine tumor patients undergoing PRRT
    In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 51, 2024, Nr. 3, S. 841 – 851
    DOI (Open Access)
  • Pavel, Marianne; Lahner, Harald; Hörsch, Dieter; Rinke, Anja; Denecke, Timm; Koch, Arend; Regnault, Benjamin; Helbig, Dorit; Hoffmanns, Philipp; Raderer, Markus
    Combined Lanreotide Autogel and Temozolomide Treatment of Progressive Pancreatic and Intestinal Neuroendocrine Tumors: The Phase II SONNET Study
    In: The Oncologist, Jg. 29, 2024, Nr. 5, S. e643 – e654
    DOI (Open Access)
  • Braegelmann, Johanna; Mathew, Annie; Führer‐Sakel, Dagmar; Lahner, Harald
    Consanguineous couple with SDHD gene mutations : Diagnosis, treatment, and implications of family genetic testing
    In: Clinical Case Reports, Jg. 12, 2024, Nr. 4, e8572
    DOI (Open Access)
  • Watanabe, Masao; Leyser, Stephan; Theysohn, Jens; Schaarschmidt, Benedikt; Ludwig, Johannes; Fendler, Wolfgang; Moraitis, Alexandros; Lahner, Harald; Mathew, Annie; Herrmann, Ken; Weber, Manuel
    Dose-Response Relationship in Patients with Liver Metastases from Neuroendocrine Neoplasms Undergoing Radioembolization with ⁹⁰Y Glass Microspheres
    In: Journal of Nuclear Medicine (JNM), Jg. 65, 2024, Nr. 8, S. 1175 – 1180
    DOI
  • Lahner, Harald; Pavel, Marianne
    Gastrointestinale neuroendokrine Tumoren  : Update 2024
    In: Die Innere Medizin, Jg. 65, 2024, Nr. 7, S. 664 – 671
    DOI
  • Mathew, Annie; Bertram, Stefanie; Rawitzer, Josefine; Nottrott, Markus; Farzaliyev, Farhad; Unger, Nicole; Weber, Frank; Dralle, Henning; Führer, Dagmar; Lahner, Harald
    Hormonal Hypersecretion and Pain : Rare But Not To Be Forgotten
    In: The American Journal of Medicine, Jg. 137, 2024, Nr. 4, S. 311 – 314
    DOI
  • Laschinsky, Christina; Welsner, Matthias; Mahabadi, Amir A.; Lahner, Harald; Hautzel, Hubertus
    NET-Induced Carcinoid Heart Disease Affecting Both Tricuspid and Aortic Valves Due to Patent Foramen Ovale and Right/Left Shunt : A Multi-imaging Challenge to Nuclear Medicine
    In: Clinical Nuclear Medicine, Jg. 49, 2024, Nr. 2, S. 157 – 159
    DOI
  • Ciuciulkaite, Ieva; Herrmann, Ken; Lahner, Harald
    Stellenwert der Peptid-Radio-Rezeptor-Therapie für das Management neuroendokriner Tumoren
    In: Die Onkologie, Jg. 30, 2024, Nr. 11, S. 1065 – 1074
    DOI
  • Mathew, Annie; Fendler, Wolfgang; Theysohn, Jens; Herrmann, Ken; Führer, Dagmar; Lahner, Harald
    Bone Metastases in Patients with Pancreatic NETs : Prevalence and Prognosis
    In: Hormone and Metabolic Research, Jg. 28, 2023, Nr. 4
    DOI
  • El Gabry, Mohamed; Arends, Sven; Shehada, Sharaf-Eldin; Lahner, Harald; Kamler, Markus; Wendt, Daniel; Spetsotaki, Konstantina
    Hedinger Syndrome – Lessons Learnt : A Single-Center Experience
    In: Journal of Cardiovascular Development and Disease, Jg. 10, 2023, Nr. 10, 413
    DOI, Online Volltext (Open Access)
  • Rosery, Vivian; Mika, Stephan; Schmid, Kurt Werner; Reis, Henning; Stuschke, Martin; Treckmann, Jürgen; Markus, Peter; Schumacher, Brigitte; Albers, David; Mende, Bastian; Lahner, Harald; Wiesweg, Marcel; Schuler, Martin; Siveke, Jens T.; Kasper, Stefan
    Identification of a new prognostic score for patients with high-grade metastatic GEP-NEN treated with palliative chemotherapy
    In: Journal of Cancer Research and Clinical Oncology, Jg. 149, 2023, Nr. 8, S. 4315 – 4325
    DOI (Open Access)
  • Remde, Hanna; Schmidt-Pennington, Laura; Reuter, Miriam; Landwehr, Laura-Sophie; Jensen, Marie; Lahner, Harald; Kimpel, Otilia; Altieri, Barbara; Laubner, Katharina; Schreiner, Jochen; Bojunga, Joerg; Kircher, Stefan; Kunze, Catarina Alisa; Pohrt, Anne; Teleanu, Maria-Veronica; Hübschmann, Daniel; Stenzinger, Albrecht; Glimm, Hanno; Fröhling, Stefan; Fassnacht, Martin; Mai, Knut; Kroiss, Matthias
    Outcome of immunotherapy in adrenocortical carcinoma : A retrospective cohort study
    In: European Journal of Endocrinology (EJE), Jg. 188, 2023, Nr. 6, S. 485 – 493
    DOI
  • Mathew, Annie; Führer, Dagmar; Lahner, Harald
    Artificial Sepsis : Think Twice Before Pausing Therapy
    In: The American Journal of Medicine, Jg. 135, 2022, Nr. 3, S. e73 – e74
    DOI
  • Kroll, Lennard; Mathew, Annie; Baldini, Giulia; Hosch, René; Koitka, Sven; Kleesiek, Jens; Rischpler, Christoph; Haubold, Johannes; Führer, Dagmar; Nensa, Felix; Lahner, Harald
    CT-derived body composition analysis could possibly replace DXA and BIA to monitor NET-patients
    In: Scientific Reports, Jg. 12, 2022, Nr. 1, 13419
    DOI, Online Volltext (Open Access)
  • Laschinsky, Christina; Herrmann, Ken; Fendler, Wolfgang; Nader, Michael; Lahner, Harald; Hadaschik, Boris; Sandach, Patrick
    Onkologische Theranostik in der Nuklearmedizin
    In: Die Radiologie, Jg. 62, 2022, Nr. 10, S. 875 – 884
    DOI
  • Laschinsky, Christina; Herrmann, Ken; Fendler, Wolfgang; Nader, Michael; Lahner, Harald; Hadaschik, Boris; Sandach, Patrick
    Onkologische Theranostik in der Nuklearmedizin
    In: Die Onkologie, Jg. 28, 2022, Nr. 7, S. 612 – 622
    DOI
  • Lahner, Harald; Mathew, Annie; Klocker, Anna Lisa; Unger, Nicole; Theysohn, Jens; Rekowski, Jan; Jöckel, Karl-Heinz; Theurer, Sarah; Schmid, Kurt Werner; Herrmann, Ken; Führer, Dagmar
    Streptozocin/5-fluorouracil chemotherapy of pancreatic neuroendocrine tumours in the era of targeted therapy
    In: Endocrine, Jg. 75, 2022, Nr. 1, S. 293 – 302
    DOI (Open Access)
  • Luecke, Simone; Fottner, Christian; Lahner, Harald; Jann, Henning; Zolnowski, Dominik; Quietzsch, Detlef; Grabowski, Patricia; Cremer, Birgit; Maasberg, Sebastian; Pape, Ulrich-Frank; Mueller, Hans-Helge; Gress, Thomas Matthias; Rinke, Anja
    Treatment Approaches and Outcome of Patients with Neuroendocrine Neoplasia Grade 3 in German Real-World Clinical Practice
    In: Cancers, Jg. 14, 2022, Nr. 11, 2718
    DOI (Open Access)
  • Schaarschmidt, Benedikt M.; Wildgruber, Moritz; Kloeckner, Roman; Nie, James; Steinle, Verena; Braat, Arthur J.A.T.; Lohoefer, Fabian; Kim, Hyun S.; Lahner, Harald; Weber, Manuel; Theysohn, Jens
    ⁹⁰Y Radioembolization in the Treatment of Neuroendocrine Neoplasms : Results of an International Multicenter Retrospective Study
    In: Journal of Nuclear Medicine (JNM), Jg. 63, 2022, Nr. 5, S. 679 – 685
    DOI (Open Access)
  • Curigliano, Giuseppe; Martin, Miguel; Jhaveri, Komal; Beck, J. T.; Tortora, Giampaolo; Fazio, Nicola; Maur, Michela; Hubner, Richard A.; Lahner, Harald; Donnet, Valerie; Ajipa, Olga; Li, Zheng; Blumenstein, Lars; Andre, Fabrice
    Alpelisib in combination with everolimus ± exemestane in solid tumours : Phase Ib randomised, open-label, multicentre study
    In: European Journal of Cancer (EJC), Jg. 151, 2021, S. 49 – 62
    DOI
  • Bruckmann, Nils Martin; Rischpler, Christoph; Kirchner, Julian; Umutlu, Lale; Herrmann, Ken; Ingenwerth, Marc; Theurer, Sarah; Lahner, Harald; Antoch, Gerald; Sawicki, Lino M.
    Correlation between contrast enhancement, standardized uptake value (SUV), and diffusion restriction (ADC) with tumor grading in patients with therapy-naive neuroendocrine neoplasms using hybrid ⁶⁸Ga-DOTATOC PET/MRI
    In: European Journal of Radiology, Jg. 137, 2021, S. 109588
    DOI
  • Matrood, Sami; Apostolidis, Leonidas; Schrader, Jörg; Krug, Sebastian; Lahner, Harald; Ramaswamy, Annette; Librizzi, Damiano; Kender, Zoltan; Kröcher, Anke; Kreutzfeldt, Simon; Gress, Thomas Matthias; Rinke, Anja
    Multicenter Analysis of Presacral Neuroendocrine Neoplasms : Clinicopathological Characterization and Treatment Outcomes of a Rare Disease
    In: Frontiers in Endocrinology, Jg. 12, 2021, 709256
    DOI (Open Access)
  • Rinke, Anja; Maintz, Christoph; Müller, Lothar; Weber, Matthias M.; Lahner, Harald; Pavel, Marianne; Saeger, Wolfgang; Houchard, Aude; Ungewiss, Hanna; Petersenn, Stephan
    Multicenter, Observational Study of Lanreotide Autogel for the Treatment of Patients with Neuroendocrine Tumors in Routine Clinical Practice in Germany and Austria
    In: Experimental and Clinical Endocrinology & Diabetes, Jg. 129, 2021, Nr. 07, S. 500 – 509
    DOI (Open Access)
  • Mathew, Annie; Führer, Dagmar; Lahner, Harald
    Sunitinib-Induced Hypothyroidism and Survival in Pancreatic Neuroendocrine Tumors
    In: Hormone and Metabolic Research, Jg. 53, 2021, Nr. 12, S. 794 – 800
    DOI (Open Access)
  • Matull, Johanna; Livingstone, Elisabeth; Wetter, Axel; Zimmer, Lisa; Zaremba, Anne; Lahner, Harald; Schadendorf, Dirk; Ugurel, Selma
    Durable Complete Response in a Melanoma Patient With Unknown Primary, Associated With Sequential and Severe Multi-Organ Toxicity After a Single Dose of CTLA-4 Plus PD-1 Blockade : A Case Report
    In: Frontiers in Oncology, Jg. 10, 2020, S. 592609
    DOI, Online Volltext (Open Access)
  • Lahner, Harald; Führer, Dagmar
    Neuroendokrine Neoplasien
    In: Der Onkologe, Jg. 26, 2020, S. 261 – 269
    DOI
  • Lahner, Harald; Führer, Dagmar
    Neuroendokrine Neoplasien des Gastrointestinaltrakts
    In: Der Gastroenterologe, Jg. 15, 2020, Nr. 2, S. 129 – 141
    DOI
  • Lahner, Harald; Fendler, Wolfgang P.; Theurer, Sarah; Unger, Nicole; Herrmann, Ken; Schmid, Kurt Werner; Führer, Dagmar
    Neuroendokrine Neoplasien des Verdauungstrakts
    In: Best Practice Onkologie, Jg. 15, 2020, Nr. 7-8, S. 320 – 333
    DOI
  • Weber, Frank; Belker, Jennifer; Unger, Nicole; Lahner, Harald; Theurer, Sarah; Schmid, Kurt Werner; Führer, Dagmar; Dralle, Henning
    Phäochromozytomatose nach Adrenalektomie : Metastasierung oder Zellverschleppung?
    In: Der Chirurg, Jg. 91, 2020, Nr. 4, S. 345 – 353
    DOI
  • Weber, Manuel; Kessler, Lukas; Schaarschmidt, Benedikt; Fendler, Wolfgang Peter; Lahner, Harald; Antoch, Gerald; Umutlu, Lale; Herrmann, Ken; Rischpler, Christoph
    Textural analysis of hybrid DOTATOC-PET/MRI and its association with histological grading in patients with liver metastases from neuroendocrine tumors
    In: Nuclear Medicine Communications, Jg. 41, 2020, Nr. 4, S. 363 – 369
    DOI
  • Weber, Manuel; Kessler, Lukas; Schaarschmidt, Benedikt; Fendler, Wolfgang Peter; Lahner, Harald; Antoch, Gerald; Umutlu, Lale; Herrmann, Ken; Rischpler, Christoph
    Treatment-related changes in neuroendocrine tumors as assessed by textural features derived from ⁶⁸Ga-DOTATOC PET/MRI with simultaneous acquisition of apparent diffusion coefficient
    In: BMC Cancer, Jg. 20, 2020, Nr. 1, 326
    DOI, Online Volltext (Open Access)
  • El Gabry, Mohamed; Shehada, Sharaf-Eldin; Mourad, Fanar; Ruhparwar, Arjang; Lahner, Harald; Dirkmann, Daniel; Thielmann, Matthias Klaus; Jakob, Heinz G.; Wendt, Daniel
    Hedinger syndrome : First experience and two-year follow-up in patients with carcinoid heart disease
    In: Journal of Thoracic Disease, Jg. 11, 2019, Nr. 8, S. 3234 – 3240
    DOI (Open Access)
  • Pavel, Marianne; Borson-Chazot, Françoise; Cailleux, Anne; Hörsch, Dieter; Lahner, Harald; Pivonello, Rosario; Tauchmanova, Libuse; Darstein, Christelle; Olsson, Håkan; Tiberg, Fredrik; Ferone, Diego
    Octreotide SC depot in patients with acromegaly and functioning neuroendocrine tumors : a phase 2, multicenter study
    In: Cancer Chemotherapy and Pharmacology, Jg. 83, 2019, Nr. 2, S. 375 – 385
    DOI
  • Singh, Simron; Carnaghi, Carlo; Buzzoni, Roberto; Pommier, Rodney F.; Raderer, Markus; Tomasek, Jiri; Lahner, Harald; Valle, Juan W.; Voi, Maurizio; Bubuteishvili-Pacaud, Lida; Lincy, Jeremie; Wolin, Edward; Okita, Natsuko; Libutti, Steven K.; Oh, Do-Youn; Kulke, Matthew; Strosberg, Jonathan; Yao, James C.; Pavel, Marianne E.; Fazio, Nicola
    Everolimus in Neuroendocrine Tumors of the Gastrointestinal Tract and Unknown Primary
    In: Neuroendocrinology, Jg. 106, 2018, Nr. 3, S. 211 – 220
    DOI (Open Access)
  • Maasberg, Sebastian; Pape, Ulrich-Frank; Fottner, Christian; Goretzki, Peter E.; Anlauf, Martin; Hörsch, Dieter; Cremer, Birgit; Schulte, Dominik M.; Quietzsch, Detlef; Scheerer, Frank; Pöpperl, Gabriele; Pöppel, Thorsten; Begum, Nehara; Grohé, Christian; Rinke, Anja; Plöckinger, Ursula; Wiedenmann, Betram; Arnold, Rudolf; Neuhaus, Peter; Knapp, Wolfram H.; Lehnert, Hendrick; Auernhammer, Christoph; Pavel, Marianne; Von Weikersthal, Ludwig Fischer; Schmidt, Bernd; Klein, Harald H.; Essler, Markus; Neumann, Jörg-Dietrich; Hamann, Susanne; Steffens, Frank; Demtröder, Frank; Kröcher, Anke; Zoicas, Flavius; Lahner, Harald; Weber, Frank; Geiler, Michael; Raffel, Andreas; Krausch, Markus; Zimmermann, Patrick; Lerch, Markus M.; Wirth, Thomas; Lang, Matthias; Ezziddin, Samer; Lammert, Frank; Bischoff, Marina; Altendorf-Hofmann, Annelore; Müller, Lothar; Hoffmeister, Albrecht; Klose, Silke; Musholt, Thomas J.; Post, Stefan; Gertler, Ralf; Scheuerlein, Hubert; Bergmann, Tanja; Bisping, Guido; Knauerhase, Andreas; Rendenbach, Bernhard; Gro, Volker; Scheurlen, Michael; Mönig, Heiner; Kudlich, Theodor; Grabowski, Patricia; Watza, Felix; Scheidhauer, Klemens; Möbius, Elke
    Neuroendokrine Neoplasien im deutschen NET-Register
    In: Zeitschrift für Gastroenterologie, Jg. 56, 2018, Nr. 10, S. 1237 – 1246
    DOI
  • Boy, Christian; Lahner, Harald; Maecke, H R; Bockisch, Andreas; Pöppel, Thorsten
    Reply to : Appearances are often deceptive
    In: Nuklearmedizin = Nuclear Medicine, Jg. 57, 2018, Nr. 4, S. 168 – 169
    DOI
  • Boy, Christian; Pöppel, Thorsten; Kotzerke, J.; Krause, B.J.; Amthauer, H.; Baum, R.P.; Buchmann, I.; Ezziddin, S.; Führer, Dagmar; Gabriel, M.; Kuwert, T.; Lahner, Harald; Lauenstein, Thomas; Maecke, H.R.; Nagarajah, James; Rösch, F.; Scheidhauer, K.; Schmidt, M.; Walter, M.A.; Bockisch, Andreas
    Somatostatinrezeptor-PET/CT : Stand: 3/2017 - AWMF-Registernummer: 031-046
    In: Nuklearmedizin = Nuclear Medicine, Jg. 57, 2018, Nr. 1, S. 4 – 17
    DOI (Open Access)
  • Carney, J. Aidan; Lyssikatos, Charalampos; Seethala, Raja R.; Lakatos, Peter; Perez-Atayde, Antonio; Lahner, Harald; Stratakis, Constantine A.
    The Spectrum of Thyroid Gland Pathology in Carney Complex : The Importance of Follicular Carcinoma
    In: The American Journal of Surgical Pathology, Jg. 42, 2018, Nr. 5, S. 587 – 594
    DOI, Online Volltext (Open Access)
  • Horsch, D.; Raderer, M.; Lahner, Harald; Rinke, A.; Denecke, T.; Koch, A.; Raspel, A.; Naschold, B.; Houchard, A.; Pavel, M.
    Combined lanreotide autogel and temozolomide in progressive neuroendocrine tumours : an interim safety analysis of the SONNET study
    In: Oncology Research and Treatment, Jg. 40, 2017, Nr. Suppl. 3, S. 238 – 238
    DOI
  • Sawicki, Lino M; Deuschl, Cornelius; Beiderwellen, Karsten; Ruhlmann, Verena; Pöppel, Thorsten; Heusch, Philipp; Lahner, Harald; Führer, Dagmar; Bockisch, Andreas; Herrmann, Ken; Forsting, Michael; Antoch, Gerald; Umutlu, Lale
    Evaluation of 68Ga-DOTATOC PET/MRI for whole-body staging of neuroendocrine tumours in comparison with 68Ga-DOTATOC PET/CT
    In: European Radiology, Jg. 27, 2017, Nr. 10, S. 4091 – 4099
    DOI
  • Yao, J.; Fazio, N.; Singh, S.; Buzzoni, R.; Carnaghi, C.; Wolin, E.; Tomasek, J.; Raderer, M.; Lahner, Harald; Voi, M.; Pacaud, L.; Lincy, J.; Valle, J.; Delle Fave, G.; Van Cutsem, E.; Oh, D. Y.; Strosberg, J.; Kulke, M.; Pavel, M.
    Everolimus (EVE) in Advanced, Nonfunctional, Well-differentiated Neuroendocrine Tumors (NET) of Gastrointestinal (GI) or Lung Origin : Second Interim Overall Survival (OS) Results From the RADIANT-4 Study
    In: Pancreas, Jg. 46, 2017, Nr. 3, S. 437 – 438
    DOI
  • Singh, S.; Carnaghi, C.; Buzzoni, R.; Raderer, M.; Lahner, Harald; Valle, J.; Voi, M.; Pacaud, L.; Lincy, J.; Okita, N.; Kulke, M.; Strosberg, J.; Yao, J.; Pavel, M.; Fazio, N.
    Everolimus for Advanced, Progressive, Nonfunctional Neuroendocrine Tumors (NET) of the Gastrointestinal (GI) Tract : Efficacy and Safety from a RADIANT-4 Subgroup Analysis
    In: Pancreas, Jg. 46, 2017, Nr. 3, S. 436 – 436
    DOI
  • Dorffel, Y.; Kullmann, F.; Lammert, F.; Quietzsch, D.; Schofl, C.; Schuppert, F.; Weber, M.; Baum, V.; Berndt, I.; Weiss, C.; Lahner, Harald
    Extension study to the open-label, multi-center, expanded access study of everolimus in patients with advanced neuroendocrine tumors
    In: Oncology Research and Treatment, Jg. 40, 2017, Nr. Suppl. 3, S. 237 – 238
    DOI
  • Pavel, Marianne E; Singh, Simron; Strosberg, Jonathan R; Bubuteishvili-Pacaud, Lida; Degtyarev, Evgeny; Neary, Maureen P; Carnaghi, Carlo; Tomasek, Jiri; Wolin, Edward; Raderer, Markus; Lahner, Harald; Valle, Juan W; Pommier, Rodney; Van Cutsem, Eric; Tesselaar, Margot E T; Fave, Gianfranco Delle; Buzzoni, Roberto; Hunger, Matthias; Eriksson, Jennifer; Cella, David; Ricci, Jean-François; Fazio, Nicola; Kulke, Matthew H; Yao, James C
    Health-related quality of life for everolimus versus placebo in patients with advanced, non-functional, well-differentiated gastrointestinal or lung neuroendocrine tumours (RADIANT-4trial) : a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
    In: The Lancet Oncology, Jg. 18, 2017, Nr. 10, S. 1411 – 1422
    DOI
  • Schramm, Sara; Lahner, Harald; Jockel, Karl-Heinz; Erbel, Raimund; Führer, Dagmar; Moebus, Susanne
    Impact of season and different vitamin D thresholds on prevalence of vitamin D deficiency in epidemiological cohorts : a note of caution
    In: Endocrine, Jg. 56, 2017, Nr. 3, S. 658 – 666
    DOI
  • Pavel, M.; Borson-Chazot, F.; Horsch, D.; Lahner, Harald; Pivonello, R.; Tauchmanova, L.; Darstein, C.; Olsson, H.; Tiberg, F.; Ferone, D.
    Results from a Phase 2, Open-Label, Multicenter, Randomized Study of the Novel, Octreotide (Oct) Subcutaneous (SC) Depot Formulation in Patients with Functioning Neuroendocrine Tumors (NETs) and Acromegaly Previously Treated with Long-Acting Octreotide
    In: Neuroendocrinology, Jg. 105, 2017, Nr. Suppl. 1, S. 203 – 203
    DOI
  • Fazio, Nicola; Buzzoni, Roberto; Baudin, Eric; Antonuzzo, Lorenzo; Hubner, Richard A; Lahner, Harald; DE Herder, Wouter W; Raderer, Markus; Teulé, Alexandre; Capdevila, Jaume; Libutti, Steven K; Kulke, Matthew H; Shah, Manisha; Dey, Debarshi; Turri, Sabine; Aimone, Paola; Massacesi, Cristian; Verslype, Chris
    A Phase II Study of BEZ235 in Patients with Everolimus-resistant, Advanced Pancreatic Neuroendocrine Tumours
    In: Anticancer Research, Jg. 36, 2016, Nr. 2, S. 713 – 719
  • Schündeln, Michael; Marschke, Laura; Bauer, Jens J; Hauffa, Pia K; Schweiger, Bernd; Führer, Dagmar; Lahner, Harald; Pöppel, Thorsten; Kiewert, Cordula; Hauffa, Berthold; Grasemann, Corinna
    A Piece of the Puzzle : The Bone Health Index of the BoneXpert Software Reflects Cortical Bone Mineral Density in Pediatric and Adolescent Patients
    In: PLoS ONE, Jg. 11, 2016, Nr. 3, S. e0151936
    DOI (Open Access)
  • Singh, S.; Carnaghi, C.; Buzzoni, R.; Pommier, R. F.; Raderer, M.; Tomasek, J.; Lahner, Harald; Valle, J. W.; Voi, M.; Bubuteishvili-Pacaud, L.; Lincy, J.; Sachs, C.; Okita, N.; Libutti, S. K.; Oh, D. Y.; Kulke, M. H.; Strosberg, J. R.; Yao, J. C.; Pavel, M. E.; Fazio, N.
    Efficacy and safety of everolimus in advanced, progressive, nonfunctional neuroendocrine tumors (NET) of the gastrointestinal (GI) tract and unknown primary : A subgroup analysis of the phase III RADIANT-4 trial
    In: Journal of Clinical Oncology (JCO), Jg. 34, 2016, Nr. Suppl. 4, S. 315
    DOI
  • Yao, James C; Fazio, Nicola; Singh, Simron; Buzzoni, Roberto; Carnaghi, Carlo; Wolin, Edward; Tomasek, Jiri; Raderer, Markus; Lahner, Harald; Voi, Maurizio; Pacaud, Lida Bubuteishvili; Rouyrre, Nicolas; Sachs, Carolin; Valle, Juan W; Delle Fave, Gianfranco; Van Cutsem, Eric; Tesselaar, Margot; Shimada, Yasuhiro; Oh, Do-Youn; Strosberg, Jonathan; Kulke, Matthew H; Pavel, Marianne E; Raderer, M; Pall, G; Van Cutsem, E; Borbath, I; Geboes, K; Peeters, M; Asmis, T; Kocha, W; Rayson, D; Ruether, J; Singh, S; Sideris, L; Kennecke, H; Wang, J; Shen, L; Xu, J; Qian, J; Jia, L; Maya, L F; Melichar, B; Sedlackova, E; Tomasek, J; Pavel, M; Bojunga, J; Malfertheiner, P; Lahner, Harald; Vogel, A; Weber, M; Hörsch, D; Kaltsas, G; Papai, Z; Toth, M; Carnaghi, C; Luppi, G; Fazio, N; Tomassetti, P; Delle Fave, G; Cartenì, G; Buzzoni, R; Barone, C; Berruti, A; Giuffrida, D; Tortora, G; Di Costanzo, F; Tafuto, S; Ito, T; Okita, N; Komoto, I; Kattan, J; Shamseddine, A; Tesselaar, M; Jarzab, B; Ruchala, M; Vladimirova, L; Raef, H; Salek, T; Ruff, P; Kim, T W; Park, Y S; Oh, D-Y; Lee, M-A; Choi, H J; Capdevila, J; Salazar, R; Zoilo, J J R; Chen, J-S; Wu, C-C; Chen, Y-Y; Chao, Y; Yeh, K-H; Sriuranpong, V; Thongprasert, S; Turna, H; Sevinc, A; Valle, J; Sarker, D; Reed, N; Cave, J; Frilling, A; Corrie, P; Fanta, P; Yao, J; Strosberg, J; Verma, U; Libutti, S; Natale, R; Pommier, R; Lubner, S; Starodub, A; Kulke, M; Sigal, D; Polite, B; Lieu, C; Hande, K; Reidy-Lagunes, D; McCollum, A; Forero, L
    Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4) : a randomised, placebo-controlled, phase 3 study
    In: Lancet, Jg. 387, 2016, Nr. 10022, S. 968 – 977
    DOI
  • Beiderwellen, Karsten; Sabet, A; Lauenstein, Thomas; Lahner, Harald; Pöppel, Thorsten
    Neuroendokrine Neoplasien des Pankreas
    In: Der Radiologe, Jg. 56, 2016, Nr. 4, S. 348 – 354
    DOI
  • Yao, J.; Fazio, N.; Singh, S.; Buzzoni, R.; Carnaghi, C.; Wolin, E.; Tomasek, J.; Raderer, M.; Lahner, Harald; Voi, M.; Pacaud, L.; Lincy, J.; Sachs, C.; Valle, J.; Delle Fave, G.; Van Cutsem, E.; Tesselaar, M. E. T.; Shimada, Y.; Oh, D. Y.; Strosberg, J.; Kulke, M. H.; Pavel, M. E.; RADIANT-4 Study Grp
    5LBA Everolimus in advanced nonfunctional neuroendocrine tumors (NET) of lung or gastrointestinal (GI) origin : Efficacy and safety results from the placebo-controlled, double-blind, multicenter, Phase 3 RADIANT-4 study
    In: European Journal of Cancer (EJC), Jg. 51, 2015, Nr. Suppl. 3, S. 709 – S710
    DOI
  • Föhring, Daniel; Möller, Lars; Führer, Dagmar; Lahner, Harald
    Artificial Hyperparathyroidism : Think Twice Before Taking Your Blood Sample
    In: The American Journal of Medicine, Jg. 128, 2015, Nr. 12, S. 21 – 22
    DOI
  • Singh, S.; Buzzoni, R.; Carnaghi, C.; Fazio, N.; Pavel, M. E.; Wolin, E. M.; Tomasek, J.; Raderer, M.; Lahner, Harald; Lam, D. H.; Cauwel, H.; Valle, J. W.; Delle Fave, G.; Van Cutsem, E.; Strosberg, J. R.; Tesselaar, M. E.; Shimada, Y.; Oh, D. Y.; Kulke, M. H.; Yao, J. C.; RADIANT-4 Study Grp
    Baseline demographics of patients from the randomized, placebo-controlled, double-blind, phase III RADIANT-4 study of everolimus in nonfunctional gastrointestinal (GI) or lung neuroendocrine tumors (NET)
    In: Journal of Clinical Oncology (JCO), Jg. 33, 2015, Nr. Suppl. 3, S. 276
    DOI
  • Pape, U. F.; Bacher, M.; Fottner, C.; Lahner, Harald; Begum, N.; Quietzsch, D.; Skrobek-Engel, G.; Pavel, M.; Rinke, A.; Maasberg, S.
    Clinical Outcome of Everolimus Treatment of Advanced Neuroendocrine Neoplasms : Real-Life Data from the German NET-Register
    In: Neuroendocrinology, Jg. 102, 2015, Nr. 1-2, S. 132
    DOI
  • Heyer, L. J.; Lahner, Harald; Ringelstein, Adrian; Heyer, C. M.; Bornfeld, Norbert
    Einseitige Aderhautfalten als Folge ausgedehnter skleraler Verkalkungen durch alimentär induzierte Hyperkalzämie
    In: Klinische Monatsblätter für Augenheilkunde, Jg. 232, 2015, Nr. 9, S. 1099 – 1100
    DOI
  • Anlauf, M; Neumann, M; Bomberg, S; Luczak, K; Heikaus, S; Gustmann, C; Antke, C; Ezziddin, S; Fottner, C; Pavel, M; Pape, U-F; Rinke, A; Lahner, Harald; Schott, M; Cremer, B; Hörsch, D; Baum, R P; Groh, U; Alkatout, I; Rudlowski, C; Scheler, P; Zirbes, T K; Hoffmann, J; Fehm, T; Gabbert, H E; Baldus, S E
    Neuroendokrine Neoplasien der Mamma
    In: Der Pathologe, Jg. 36, 2015, Nr. 3, S. 261 – 270
    DOI
  • Pöppel, Thorsten; Boy, Christian; Bockisch, Andreas; Kotzerke, J; Buchmann, I; Ezziddin, S; Scheidhauer, K; Krause, B J; Schmidt, D; Amthauer, H; Rösch, F; Nagarajah, James; Führer, Dagmar; Lahner, Harald; Pöpperl, G; Hörsch, D; Walter, M A; Baum, R P
    Peptidrezeptor-Radionuklidtherapie Somatostatinrezeptor-exprimierender Tumore
    In: Nuklearmedizin = Nuclear Medicine, Jg. 54, 2015, Nr. 1, S. 1 – 11
    DOI
  • Lahner, Harald; Tsiogka, Maria; Miller, Dorothea; Kreitschmann-Andermahr, Ilonka; Führer, Dagmar
    Carney complex : Coincidence of ACTH and GH excess
    In: Experimental and Clinical Endocrinology & Diabetes, Jg. 122, 2014, Nr. 3, OP5_26
    DOI
  • Anlauf, M; Sipos, B; Boeck, I; Baldus, S E; Heikaus, S; Krausch, M; Knoefel, W T; Begum, N; Goretzki, P; Schott, M; Auernhammer, C J; Cremer, B; Rinke, A; Ezziddin, S; Fottner, C; Pöpperl, G; Lahner, Harald; Hörsch, D; Gabbert, H E; Komminoth, P; Perren, A; Klöppel, G; Wiedenmann, B; Pavel, M; Pape, U
    Neuroendokrine Neoplasien des distalen Jejunums und Ileums
    In: Der Pathologe, Jg. 35, 2014, Nr. 3, S. 283 – 294
    DOI
  • Lahner, Harald; Gromotka, E.; Unger, Nicole; Führer, Dagmar
    Streptozotocin-based chemotherapy in pNET : A single-centre experience
    In: Experimental and Clinical Endocrinology & Diabetes, Jg. 122, 2014, Nr. 3, S. P108
    DOI
  • Sandritter, B; Lahner, Harald; Schopohl, J; Bojunga, J; Jungmann, G
    Can a homecare service improve the Quality of Life (QoL) and treatment satisfaction for patients (pts) while maintaining the remisson rate during Sandostatin® LAR® treatment?
    In: Experimental and Clinical Endocrinology & Diabetes, Jg. 121, 2013, S. P70
    DOI
  • Pasieka, Mareike; Thavarajah, S; Adamzik, Michael; Paul, Andreas; Weber, Frank; Lahner, Harald
    Fulminant progressive thyroid cyst with tracheal compression - a case report
    In: Experimental and Clinical Endocrinology & Diabetes, Jg. 121, 2013, Nr. 3, S. P23
    DOI
  • Tsioga, M; Voigtländer, Richard; Suttorp, W; Zimmer, Lisa; Schlamann, Marc; Sure, Ulrich; Lahner, Harald; Moeller, LC; Führer, Dagmar
    Immune-related hypophysitis in three patients with metastatic melanoma undergoing Ipilimumab treatment
    In: Experimental and Clinical Endocrinology & Diabetes, Jg. 121, 2013, S. P10
    DOI
  • Schlamann, Marc; Sure, Ulrich; Keyvani, Kathy; Lahner, Harald; Führer, Dagmar; Unger, Nicole
    Malignant Prolactinoma - a therapeutic challenge
    In: Experimental and Clinical Endocrinology & Diabetes, Jg. 121, 2013
    DOI
  • Muchalla, Philipp; Schramm, Sara; Lahner, Harald; Roggenbuck, U.; Moebus, Susanne; Erbel, Raimund; Jöckel, Karl-Heinz; Führer, Dagmar; Möller, Lars
    Prevalence of thyroid dysfunction and age dependency of TSH in a population-based study : Results from the Heinz Nixdorf Recall Study (HNR)
    In: Experimental and Clinical Endocrinology & Diabetes, Jg. 121, 2013, Nr. 3, S. P16
    DOI
  • Lahner, Harald; Schramm, Sara; Jöckel, Karl-Heinz; Erbel, Raimund; Mann, Klaus; Führer, Dagmar; Moebus, Susanne; Heinz Nixdorf Recall study Investigative Group
    Prevalence of vitamin D deficiency in a population-based study : Results from the Heinz Nixdorf Recall Study
    In: Experimental and Clinical Endocrinology & Diabetes, Jg. 121, 2013, Nr. 3, OP10_64
    DOI
  • Führer, Dagmar; Lahner, Harald; Rinke, A; Pöppel, TD
    Sunitinib in pancreatic neuroendocrine tumours
    In: Experimental and Clinical Endocrinology & Diabetes, Jg. 121, 2013, S. P60
    DOI
  • Hartung-Knemeyer, V.; Müller, Stefan; Nagarajah, James; Lahner, Harald; Bröcker-Preuß, Martina; Bockisch, Andreas; Görges, Rainer
    Assay-Abhängigkeit der Calcitonin- Zielbereiche für „biochemisch geheilte“ Patienten mit medullärem Schilddrüsenkarzinom
    In: Nuklearmedizin = Nuclear Medicine, Jg. 51, 2012, Nr. 4, S. 125 – 132
    DOI
  • Schramm, Sara; Lahner, Harald; Jöckel, Karl-Heinz; Moebus, Susanne
    Impact of various national and international Limits for Vitamin D DEficiency in a population-based Study
    In: Das Gesundheitswesen, Jg. 74, 2012, Nr. 8-9, S. 587 – 587
  • Pöppel, Thorsten; Binse, Ina; Lahner, Harald; Lauenstein, Thomas; Bockisch, Andreas; Boy, Christian
    Y-90-DOTATOC PET/CT for acquisition of biodistribution following peptide receptor radionuclide therapy
    In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 39, 2012, Nr. Suppl. 2, S. S331 – S332
  • Pöppel, Thorsten; Binse, Ina; Petersenn, Stephan; Lahner, Harald; Schott, Matthias; Antoch, Gerald; Brandau, Wolfgang; Bockisch, Andreas; Boy, Christian
    68Ga-DOTATOC versus 68Ga-DOTATATE PET/CT in Functional Imaging of Neuroendocrine Tumors
    In: Journal of Nuclear Medicine (JNM), Jg. 52, 2011, Nr. 12, S. 1864 – 1870
    DOI
  • Pöppel, Thorsten; Binse, I.; Petersenn, Stephan; Lahner, Harald; Schott, M.; Antoch, G.; Brandau, Wolfgang; Bockisch, Andreas; Boy, Christian
    68Ga-DOTATOC vs. 68Ga-DOTATATE PET/CT in functional imaging of Neuroendocrine Tumours
    In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 38, 2011, Nr. Suppl. 2, S. 97 – S98
  • Deutschbein, T.; Unger, Nicole; Yüce, Ali; Eberhardt, Wilfried; Gauler, Thomas; Lahner, Harald; Mann, Klaus; Petersenn, Stephan
    Chemotherapy in Patients with Progressive, Undifferentiated Neuroendocrine Tumors : A Single-Center Experience
    In: Hormone and Metabolic Research, Jg. 43, 2011, Nr. 12, S. 838 – 843
    DOI
  • Alesina, Pier F.; Singaporewalla, Reyaz M.; Eckstein, Anja; Lahner, Harald; Walz, Martin
    Is minimally invasive, video-assisted thyroidectomy feasible in Graves' disease?
    In: Surgery, Jg. 149, 2011, Nr. 4, S. 556 – 560
    DOI
  • Deutschbein, T.; Matuszczyk, Anna; Möller, Lars; Unger, Nicole; Yüce, Ali; Lahner, Harald; Mann, Klaus; Petersenn, Stephan
    Treatment of Advanced Medullary Thyroid Carcinoma with a Combination of Cyclophosphamide, Vincristine, and Dacarbazine : a Single-Center Experience
    In: Experimental and Clinical Endocrinology & Diabetes, Jg. 119, 2011, Nr. 9, S. 540 – 543
    DOI
  • Tan, Susanne; Bechmann, Lars Peter; Benson, Sven; Dietz, Tiina; Eichner, Stefanie; Hahn, Susanne; Janßen, Onno Eilard; Lahner, Harald; Gerken, Guido; Mann, Klaus; Canbay, Aliekber
    Apoptotic markers indicate nonalcoholic steatohepatitis in polycystic ovary syndrome
    In: The Journal of Clinical Endocrinology & Metabolism (JCEM), Jg. 95, 2010, Nr. 1, S. 343 – 348
    DOI
  • Berg, Christian; Petersenn, Stephan; Lahner, Harald; Herrmann, Burkhard; Buchfelder, Michael; Droste, Michael; Stalla, G̈unter K.; Strasburger, Christian J.; Roggenbuck, Ulla; Lehmann, Nils; Moebus, Susanne; Jöckel, Karl-Heinz; Möhlenkamp, Stephan; Erbel, Raimund; Saller, Bernhard; Mann, Klaus
    Cardiovascular risk factors in patients with uncontrolled and long-term acromegaly : Comparison with matched data from the general population and the effect of disease control
    In: The Journal of Clinical Endocrinology & Metabolism (JCEM), Jg. 95, 2010, Nr. 8, S. 3648 – 3656
    DOI
  • Berg, Christian; Meinel, Timo; Lahner, Harald; Yüce, Ali; Mann, Klaus; Petersenn, Stephan
    Diagnostic utility of the glucagon stimulation test in comparison to the insulin tolerance test in patients following pituitary surgery
    In: European Journal of Endocrinology (EJE), Jg. 162, 2010, Nr. 3, S. 477 – 482
    DOI
  • Tan, Susanne; Scherag, Andre; Janßen, Onno Eilard; Hahn, Susanne; Lahner, Harald; Dietz, Tiina; Scherag, Susann; Grallert, Harald; Vogel, Carla I.G.; Kimmig, Rainer; Illig, Thomas; Mann, Klaus; Hebebrand, Johannes; Hinney, Anke
    Large effects on body mass index and insulin resistance of fat mass and obesity associated gene (FTO) variants in patients with polycystic ovary syndrome (PCOS)
    In: BMC Medical Genetics, Jg. 11, 2010, 12
    DOI (Open Access)
  • Alesina, Pier F.; Hommeltenberg, Silvia; Meier, Beate; Petersenn, Stephan; Lahner, Harald; Schmid, Kurt Werner; Mann, Klaus; Walz, Martin
    Posterior Retroperitoneoscopic Adrenalectomy for Clinical and Subclinical Cushing’s Syndrome
    In: World Journal of Surgery, Jg. 34, 2010, Nr. 6, S. 1391 – 1397
    DOI
  • Berg, Christian; Meinel, Timo; Lahner, Harald; Mann, Klaus; Petersenn, Stephan
    Recovery of pituitary function in the late-postoperative phase after pituitary surgery : Results of dynamic testing in patients with pituitary disease by insulin tolerance test 3 and 12 months after surgery
    In: European Journal of Endocrinology (EJE), Jg. 162, 2010, Nr. 5, S. 853 – 859
    DOI
  • Berg, Christian; Petersenn, Stephan; Lahner, Harald; Herrmann, Burkhard; Buchfelder, M.; Droste, M.; Stalla, G. K.; Strasburger, C. J.; Roggenbuck, U.; Lehmann, Nils; Moebus, Susanne; Jöckel, Karl-Heinz; Möhlenkamp, Stefan; Erbel, Raimund; Saller, Bernhard; Mann, Klaus
    The Effect of Pegvisomant on Cardiovascular Risk in Patients with Active Acromegaly in Comparison to Matched Data from the General Population
    The Endocrine Society’s 92nd Annual Meeting & Expo, 1 June 2010,
    In: Endocrine Reviews, Jg. 31, 2010, Nr. 3, Suppl. 1, S. 857, OR16-6
    DOI
  • Matuszczyk, Anna; Petersenn, Stephan; Lahner, Harald; Haude, Michael; Veit, Patrick; Becker, Jan U.; Kimmig, Rainer; Bockisch, Andreas; Mann, Klaus
    Androgenproduzierender Leydig-Zell-Tumor des Ovars als Ursache von Hirsutismus bei einer postmenopausalen Frau
    In: Medizinische Klinik, Jg. 102, 2007, Nr. 3, S. 259 – 262
    DOI

    • Abstracts

  • Braat, A.; Walter, T.; de Vries-Huizing, D.; Theysohn, Jens; Lahner, Harald
    166Holmium-SIRT after PRRT (HEPAR PLuS) versus PRRT-only in Patients with Metastatic Neuroendocrine Tumors: a Propensity-score Matched Analysis
    Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023 Vienna, Austria,
    In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 50, 2023, Nr. 1 supplement, S. S379
    DOI
  • Leyser, Stephan; Lanzafame, Helena; Kersting, David; Seifert, Robert; Zarrad, Fadi; Lahner, Harald; Unger, Nicole; Fendler, Wolfgang; Herrmann, Ken; Weber, Manuel
    Prognostic value of the post-treatment 177Lu-DOTATOC scintigraphy in NET patients undergoing PRRT
    Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023, Vienna, Austria,
    In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 50, 2023, Nr. 1 supplement, S. S134
    DOI
  • Weber, Manuel; Pettersson, O.; Seifert, R.; Schaarschmidt, B. M.; Fendler, Wolfgang P.; Rischpler, Christoph; Lahner, Harald; Herrmann, Ken; Sundin, A.
    Changes in Tumor-Blood Ratio as a prognostic marker for progression-free survival and overall survival in neuroendocrine tumor patients undergoing PRRT
    EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,
    In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 49, 2022, Nr. Supplement 1, S. S80
    DOI (Open Access)
  • Luecke, S.; Fottner, C.; Lahner, Harald; Jann, H.; Zolnowski, D.; Grabowski, P.; Cremer, B.; Quietzsch, D.; Maasberg, S.; Pape, U. F.; Gress, T. M.; Rinke, A.
    Treatment outcomes of patients with G3 neuroendocrine neoplasms Data from the German NET Registry
    18th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease 25 – 27 February 2021,
    In: Journal of Neuroendocrinology: Wiley, Jg. 33, 2021, Nr. S1, S. 72
    DOI (Open Access)
  • Pavel, M.; Denecke, T.; Lahner, Harald; Hörsch, D.; Rinke, A.; Koch, A.; Liyanage, N.; Raspel, A.; Pape, U. F.; Raderer, M.
    Disease Control in Progressive Pancreatic and Intestinal Neuroendocrine Tumors by Combined Treatment with Lanreotide Autogel and Temozolomide : The SONNET Study
    15th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease ; March 7–9, 2018, Barcelona,
    In: Neuroendocrinology. Basel: Karger, Jg. 106, 2018, Nr. Suppl. 1, S. 202
    DOI (Open Access)
  • Pavel, M.; Denecke, T.; Lahner, Harald; Hörsch, D.; Rinke, A.; Koch, A.; Hoffmanns, P.; Liyanage, N.; Raspel, A.; Pape, U.-F.; Raderer, M.
    Disease control in progressive pancreatic and intestinal neuroendocrine tumours with combined treatment with lanreotide Autogel and temozolomide : the SONNET study
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 41, 2018, Nr. Suppl. 4, S. 263
    DOI (Open Access)
  • Nadjm, S.; Exner, J. P.; Gauler, Thomas; Pöttgen, Christoph; Darwiche, Kaid; Cheufou, D.; Krebs, B.; Metzenmacher, M.; Oezkan, F.; Rebmann, Vera; Umutlu, Lale; Deuschl, C.; Li, Y.; Lahner, Harald; Christoph, Daniel; Hoiczyk, M.; Witzke, Oliver; Hoffmann, Andreas-Claudius; Aigner, Clemens; Theegarten, Dirk; Taube, Christian; Schuler, Martin; Stamatis, Georgios; Stuschke, Martin; Eberhardt, Wilfried
    Long-term Survival(LTS) and Survivorship Program(SS-P) of Lung Cancer(LC) Patients(Pts). Investigations(Invest) on LT-toxicities(Tox) and late morbidities(Morb)
    33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 41, 2018, Nr. Suppl. 1, S. 108
    DOI (Open Access)
  • Raderer, M.; Horsch, D.; Lahner, Harald; Rinke, A.; Denecke, T.; Koch, A.; Raspel, A.; Hoffmanns, P.; Pavel, M.
    Combination of Lanreotide Autogel and Temozolomide in Patients with Progressive Gastro-Entero-Pancreatic Neuroendocrine Tumours (GEP-NET) - A Pilot-Study
    In: Neuroendocrinology. Basel: Karger, Jg. 103, 2016, Nr. Suppl. 1, S. 75 – 75
    DOI
  • Singh, S.; Carnaghi, C.; Buzzoni, R.; Raderer, M.; Lahner, Harald; Valle, J.; Voi, M.; Bubuteishvili-Pacaud, L.; Lincy, J.; Okita, N.; Kulke, M.; Strosberg, J.; Yao, J.; Pavel, M.; Fazio, N.
    Everolimus for Advanced, Progressive, Nonfunctional Neuroendocrine Tumors (NET) of the Gastrointestinal (GI) Tract : Efficacy and Safety from a RADIANT-4 Subgroup Analysis
    In: Neuroendocrinology. Basel: Karger, Jg. 103, 2016, Nr. Suppl. 1, S. 85 – 85
    DOI
  • Lahner, Harald; Weber, M.; Horsch, D.; Bojunga, J.; Vogel, A.; Voi, M.; Pacaud, L.; Pavel, M.
    Secondary analysis from the RADIANT-4 trial : Impact of prior Somatostatin Analogue (SSA) use on progression-free survival in patients with advanced nonfunctional Neuroendocrine Tumors (NET) of lung or Gastrointestinal (GI) origin
    In: Oncology Research and Treatment. Basel: Karger, Jg. 39, 2016, Nr. Suppl. 3, S. 281 – 282
    DOI
  • Lahner, Harald; Weber, M.; Horsch, D.; Bojunga, J.; Vogel, A.; Voi, M.; Pacaud, L.; Pavel, M.
    Secondary analysis from the phase 3 RADIANT-4 trial : Evaluating the impact of prior chemotherapy (CTx) on progression-free survival in patients with advanced, nonfunctional neuroendocrine tumors (NET) of lung or gastrointestinal (GI) origin
    In: Oncology Research and Treatment. Basel: Karger, Jg. 39, 2016, Nr. Suppl. 3, S. 281
    DOI
  • Pöppel, Thorsten; Ngo, H. V.; Binse, Ina; Lahner, Harald; Unger, Nicole; Bellendorf, Alexander; Ezziddin, S.; Bockisch, Andreas; Sabet, A.
    Pre-treatment intensity of DOTATOC uptake for prediction of response to selective intravascular radionuclide therapy
    28th Annual EANM Congress of the European Association of Nuclear Medicine, 10-14 October 2015, Hamburg, Germany,
    In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 42, 2015, Nr. Suppl. 1, S. S8 – S9
    DOI
  • Lahner, Harald; Dorffel, Y.; Bojunga, J.
    Health-related Quality-of-Life in everolimus-treated patients with advanced neuroendocrine tumors : results from an open-label, phase IIIb, multicenter, expanded access program (EVIDENT)
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 10.-14. Oktober 2014, Hamburg,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 37, 2014, Nr. Suppl. 5, S. 152
    DOI
  • Muchalla, Philipp; Schramm, Sara; Lahner, Harald; Roggenbuck, U.; Moebus, Susanne; Erbel, Raimund; Jöckel, Karl-Heinz; Führer, Dagmar; Moller, L.
    Prevalence of thyroid dysfunction and age dependency of TSH in a population-based study : Results from the Heinz Nixdorf Recall Study
    In: Der Internist. Berlin: Springer Medizin, Jg. 54, 2013, Nr. Suppl. 1, 119. Kongress der Deutschen Gesellschaft für Innere Medizin e.V., 06. - 09. April 2013, Wiesbaden, S. 18 – 19
    DOI
  • Deutschbein, T.; Unger, Nicole; Yüce, Ali; Lahner, Harald; Mann, Klaus; Petersenn, Stephan
    Chemotherapy in the Treatment of Progressive, Undifferentiated Neuroendocrine Carcinomas : A Single-Center Experience
    7th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease March 11–12, 2010 Berlin, Germany,
    In: Neuroendocrinology. Basel: Karger, Jg. 92, 2010, Nr. 1, S. 27
    DOI

    • Beiträge in Sammelwerken und Tagungsbänden

  • Nagel, Isabel; Herrmann, Ken; Lahner, Harald; Rischpler, Christoph; Weber, Frank
    Combined medical therapy, nuclear medicine therapy and other therapies in metastatic neuroendocrine tumor
    In: Nuclear Medicine and Molecular Imaging: Volume 4: Nuclear Medicine Therapy / Signore, Alberto / Sathekge, Mike; Luster, Markus (Hrsg.). Amsterdam: Elsevier, 2022, S. 145 – 156
    DOI
  • Pöppel, Thorsten; Binse, Ina; Petersenn, Stephan; Lahner, Harald; Schott, Matthias; Antoch, Gerald; Brandau, Wolfgang; Bockisch, Andreas; Boy, Christian
    Differential Uptake of 68Ga-DOTATOC and 68Ga-DOTATATE in PET/CT of Gastroenteropancreatic Neuroendocrine Tumors
    In: Theranostics, Gallium-68, and Other Radionuclides: A Pathway to Personalized Diagnosis and Treatment / Baum, Richard P.; Rösch, Frank (Hrsg.). Heidelberg: Springer, 2013, S. 353 – 371
    DOI

    • Poster / Posterbeiträge

  • Boy, Christian; Ezziddin, S.; Rosenbaum-Krumme, Sandra; Nagarajah, James; Fichtner, C.; Brandau, Wolfgang; Lauenstein, Thomas; Lahner, Harald; Sheu, Sien-Yi; Bockisch, Andreas; Poeppel, D.
    Lack of Somatostatin Receptor Subtype-2 (SSTR2) in the Normal Human Thyroid Gland at Protein Level : Apparent Discrepancy of Immunohistochemistry and Gender-Specific Uptake of 68Ga-DOTATOC?
    27th Annual Congress of the European Association of Nuclear Medicine, October 18–22, 2014, Gothenburg, Sweden,
    In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 41, 2014, Nr. Suppl. 2, S. S411
    DOI